Recorlev is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Xeris Pharmaceuticals, Inc.. The primary component is Levoketoconazole.
| Product ID | 72065-003_0673111d-f8e9-46d1-b015-a29683c2705e |
| NDC | 72065-003 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Recorlev |
| Generic Name | Levoketoconazole |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2021-12-30 |
| Marketing Category | NDA / |
| Application Number | NDA214133 |
| Labeler Name | Xeris Pharmaceuticals, Inc. |
| Substance Name | LEVOKETOCONAZOLE |
| Active Ingredient Strength | 150 mg/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2021-12-30 |
| NDC Exclude Flag | N |
| Sample Package? | N |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() RECORLEV 86865505 not registered Live/Pending |
Cortendo AB 2016-01-05 |